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PURPOSE. To compare phenotype variability in retinitis pigmentosa patients with recessive and
dominant mutations in the SNRNP200 gene.
METHODS. In a retrospective study, patients of two unrelated families were identified: family A,
five patients aged 36 to 77 years; family B, one patient aged 9 years and his asymptomatic
parents and sister. All patients received a comprehensive eye examination with a detailed retinal
functional and morphologic assessment. Genetic testing was performed by whole exome
sequencing (WES) in the index patient from each family. Genes described to be involved in eye
diseases (n > 450) were screened for rare variants and segregation analysis was performed.
RESULTS. A known heterozygous missense variant (c.3260C>T, p.(Ser1087Leu)) in the
SNRNP200 gene was identified in the index patient of family A while a novel homozygous
missense mutation (c.1634G>A, p.(Arg545His)) was found in the index patient of family B.
Nyctalopia and photophobia were reported by 6/6 and 2/6 patients, respectively. The
phenotype associated with the dominant mutation was characterized by variable disease
onset (early childhood to the sixth decade of life), disease severity (visual acuity of 20/20–20/
200 in the seventh to eighth decade), and advanced rod-cone dysfunction. Characteristics of
recessive disease included distinct fundus changes of dot-like hypopigmentation together
with retinal atrophy and severe rod-cone dysfunction.
CONCLUSIONS. The phenotype characteristics in autosomal dominant and recessive SNRNP200
mutations show distinct features, with earlier severe disease in the recessive case and a
variable disease expression in the dominant inheritance pattern.
Keywords: SNRNP200, retinitis pigmentosa, autosomal dominant, autosomal recessive,
genotype phenotype correlation
The gene small nuclear ribonucleoprotein U5 subunit 200(SNRNP200) codes for a splicing factor, designated HELIC2,
and is essential for unwinding of U4/U6 RNA duplices—an
important step in the catalytic activation of the spliceosome.1–3
The SNRNP mutation c.3260C>T, p.(Ser1087Leu) was initially
described in two Chinese families with nonsyndromic autosomal
dominant retinitis pigmentosa (RP).4,5 Benaglio et al.6 estimated
a high prevalence of SNRNP200 mutations among Caucasian
autosomal dominant RP patients of at least 4.2%. A study among
the French Canadian founder population revealed mutations in
SNRNP200 in 17% of the cases where a disease-associated
mutation was detected (60 patients tested in total; 4 out of 17
mutations occurred in SNRNP200).7 SNRNP200 mutations were
also identified in 1/163 (mutation frequency 0.6%) patients with
cone-rod dystrophy (CORD).8 Autosomal recessive inheritance
has been suggested by several authors,9–11 since homozygous9,11
as well as possibly compound heterozygous mutations10 in the
SNRNP200 gene have been identified. The reported range of
phenotypes varies from Leber congenital amaurosis (LCA)
caused by a homozygous mutation9 to juvenile RP. A recent
report by Zhou et al.12 suggested an association between early-
onset high myopia (eoHM) and heterozygous SNRNP200
missense mutations, although no retinal functional testing in
the reported patients was documented. Most of the mutations in
the SNRNP200 gene are missense mutations, with two
exceptions: c.2036þ1G>T affects the splice donor site of exon
15 and c.2941-2A>G the splice acceptor site of exon 22, as
illustrated in Figure 1. Here, we elucidate and compare the
retinal phenotype in patients with a previously described
dominant SNRNP200 mutation to an affected individual with a
novel recessive SNRNP200 variant.
METHODS
This is a retrospective description and analysis of the genotype
and phenotype of patients with mutations in the SNRNP200
gene. This work was approved by the Cantonal Ethics
Committee of Zurich and adhered to the tenets of the
Declaration of Helsinki.
Copyright 2019 The Authors
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Ocular Phenotype
All patients were seen and examined in the course of the
clinical practice of the first author (C.G-K.) between November
2016 and April 2018.
All patients and available family members received a full
ophthalmologic examination including measurement of visual
acuity, dilated fundoscopy, optical coherence tomography
(OCT; Spectralis; Heidelberg Engineering GmbH, Heidelberg,
Germany), kinetic perimetry (Octopus 900 or manual Gold-
mann perimeter; Haag-Streit AG, Ko¨niz, Switzerland), full-field
electroretinography (ff-ERG; Espion; Diagnosys LLC, Lowell,
MA, USA), autofluorescence (AF) examination using the
Optomap (Optos plc, Dunfermline, UK) and/or Heidelberg
Spectralis, and fundus photography. In patients and affected
family members with sufficient visual acuity and adequate
fixation it was also possible to perform multifocal electroret-
inography (mf-ERG) with the Espion system also used for ff-
ERG recording.
When possible, OCT was performed in high-resolution
mode using a volume scan (31 horizontally aligned sections
separated by 245 lm covering a retinal area of 308 horizontally
3 258 vertically; 15 Automatic Real-time Tracking [ART] scans
averaged) centered on the fovea. The precise settings used
were amended when circumstances dictated (e.g., when poor
vision or inability to maintain fixation in a patient or affected
family member rendered the standard scans unfeasible); using
this approach, it was possible to obtain some form of OCT
scan, even if just a single section, in all patients and examined
family members. All scans were inspected for segmentation
errors by a single author (J.V.M.H.), and the definitions of the
inner limiting membrane and Bruch’s membrane were, when
necessary, corrected. Due to afoveal fixation it was not possible
to use the 1-, 3-, 6-mm Early Treatment Diabetic Retinopathy
Study (ETDRS) grid when calculating total macular volume
(TMV) in some patients with severe visual loss; therefore the 1-,
2.22-, 3.45-mm grid was employed for all patients instead, in
order to facilitate comparison of TMV values across all patients
who were able to yield a volume scan.
As with OCT, the precise nature of the kinetic perimetry
examinations was dependent on the residual visual quality and
consequent ability to perform the examination of the patients
and affected family members. When possible, V4e, I4e, and I2e
isopters were kinetically measured and verified with presen-
tation of scattered static stimuli; as a minimum, V4e isopters
were measured and statically verified.
Ff-ERG and mf-ERG were recorded according to published
recommendations of the Society for Clinical Electrophysiology
of Vision.13 Medical mydriasis was accomplished using topical
0.5% tropicamide and 5% phenylephrine. Gold-plated skin
electrodes at the ipsilateral outer canthi (reference) and center
of the forehead (ground) were used, together with single-use
Dawson-Trick-Litzkow recording electrodes (Diagnosys LLC).
Before applying skin electrodes, the patients’ skin was cleaned
and scrubbed using ethanol-based hand disinfectant and an
abrasive paste in order to minimize electrical impedance
during recording. Topical 0.4% oxybuprocaine was instilled
prior to positioning the DTL electrodes in order to minimize
patient discomfort.
Recording of the ERG was preceded by a period of dark
adaptation lasting 20 minutes. Following this, patients were
presented with 0.01-cd/m2 flashes (‘‘rod’’) followed by 3.0-cd/
m2 flashes (‘‘rod-cone’’) in order to measure the responses of
the rod system and combined rod-cone systems, respectively.
Patients were then adapted to a rod-bleaching 30-cd/m2 light
for 10 minutes before being presented with 3.0-cd/m2 light,
both flickering (30-Hz frequency; ‘‘cone flicker’’) and as single
flashes (at a frequency of 1 Hz; ‘‘cone’’). All stimuli were
delivered via a diffusing full-field stimulator and were
composed of white light. Multiple responses were recorded,
which were assessed and accepted or rejected online in order
FIGURE 1. Schematic drawing of the SNRNP200 protein consisting of 2136 amino acid residues and their functional domains according to Zhang et
al.43 Disease-causing mutations are indicated at the protein level. Most of them are missense mutations, with two exceptions: c.2036þ1G>T affects
the splice donor site of exon 15 and c.2941-2A>G the splice acceptor site of exon 22. The majority of mutations are dominant and lead to retinitis
pigmentosa except when indicated otherwise. Recessive mutations are indicated by an asterisk. RD, retinal dystrophy.
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to verify reproducibility and ensure that the averaged
potentials were uncontaminated by visible artifacts.
Recording of the mf-ERG was performed in normal room
illumination using an achromatic 61-hexagon stimulus array
covering approximately 508 of the central visual field.
Individual hexagons had a luminance of either 400 or 0.0 cd/
m2, which was determined for each hexagon according to a 14-
bit M-sequence at 75 Hz. Recordings were bandpass filtered
(10–100 Hz) in order to remove extraneous electrical noise.13
Each recording session lasted 30 seconds, with a minimum of
eight sessions required to complete the mf-ERG recording.
Molecular Genetic Testing
DNA for whole exome sequencing (WES) was extracted from
peripheral blood. Library preparation for next-generation
sequencing (NGS) was performed according to the manufac-
turer’s protocol using either Illumina (San Diego, CA, USA)
Nextera Rapid Capture Exome (index patient of family A) or
Illumina TruSeq Exome kit (index patient of family B). Paired-
end NGS sequencing was performed on an Illumina Nex-
Seq500 platform (cycles: 23 150 for index patient of family A,
2 3 75 for index patient of family B). Alignment and variant
calling were performed on an Illumina BaseSpace on-site
server. VCF files were annotated by using Alamut Batch
(version 1.9; Interactive Biosoftware, Rouen, France) with an
in-house gene list (n ¼ 483) of known or potential candidate
genes involved in eye diseases, in particular retinal disorders.
Variants were filtered for either presence in the Human Gene
Mutation Database (HGMD) or frequency (<1%) in the non-
Finnish European population (gnomAD database, Lek et al.14).
Missense variants were considered when they were predicted
to be disease causing by at least three of the following five
algorithms: Align GVGD, SIFT, MAPP, MutationTaster2, or
PolyPhen2.
Copy number variation (CNV) analysis was performed by
analysis of exome NGS data using cn.MOPS15 and EXCAVA-
TOR216 software.
Sanger sequencing was performed for segregation analysis
as previously described by Haghighi et al.17
RESULTS
Two unrelated families were identified with heterozygous
(family A) or homozygous (family B) amino acid substitutions in
the SNRNP200 (NM_014014.4) gene (Fig. 2). The families
were of Caucasian ethnicity, originating from Switzerland
(family A) and Kosovo (family B), and both without known
consanguinity (Fig. 3).
Family A: Autosomal-Dominant RP Caused by a
Heterozygous Missense Mutation (c.3260C>T
p.(Ser1087Leu)) in SNRNP200
Detailed data from five affected family members were available
(Figs. 4–6; Tables 1, 2). The index patient III:1 was first
examined at our institution because of intermittent exotropia,
which resolved after subsequent strabismus surgery. Age at
first symptoms varied between early childhood and around 55
years. All patients complained of nyctalopia as their first
symptom, with photophobia developing in three of the five
examined patients during their disease course. The index
patient of this family (III:1) was first diagnosed at the age of 5
FIGURE 2. Sequencing analysis of SNRNP200 (NM_014014.4) variants. (A) Sanger sequencing results of family A index patient, selected affected
family members, and a representative nonaffected family member are shown. (B) WES analysis of family B index and Sanger sequencing results of
the parents and sister of the index patient.
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years. He received parabulbar injections of benzyl-imidazoline
at an outside institution between ages 5 and 12 years
(according to the patient, in order to control the retinal
disease), but no further information or documentation was
available to us. All patients in this family reported a slow but
relentless progression of their vision loss while nevertheless
being able to study and maintain employment in demanding
professions. The index patient and affected relatives were all
moderately to highly myopic from early childhood onward
(Table 1).
Best-corrected visual acuity ranged from 20/20 (patient II:2
at age 67) to 20/100 to 20/200 (patients II:4 and II:5 at ages 66
and 77, respectively) (Table 1). Patient II:5 experienced
complete loss of vision (no light perception; NLP) in the right
eye due to an intracerebral meningioma (no further details
available). Analysis of the visual fields demonstrated an
advanced midperipheral and nasal field loss in the fourth
decade (III:1 and III:3) and a small residual central island only
FIGURE 3. Pedigrees of the two unrelated families are shown.
Consanguinity is not known in either family, originating in Switzerland
(family A) and in Kosovo (family B).
FIGURE 4. Retinal morphology (fundus photography, corresponding autofluorescence [AF] images, and horizontal spectral-domain OCT scans
through the fovea, arranged from left to right, respectively) of both eyes is shown for all affected patients from family A and the one patient of family
B. OCT scans are displayed with the right eye uppermost for each patient. Composite fundus photography of patient II:2 shows mildly atrophic
maculae, midperipheral bone spicule pigmentation, central hyperAF, and cystoid macular edema (CME) confined to the inner nuclear layer (INL).
Patient III:1 shows less generalized, but already marked, circumscribed islands of chorioretinal atrophy, ring-shaped hyperAF, and CME. Patient II:4
displays generalized atrophy that is more severe nasally to the optic nerve head, ring-shaped hyperAF, cystic macular lesions in the right eye only,
and reduced macular thickness in both eyes. Composite fundus photography in patient III:3 shows relatively little retinal atrophy in the presence of
bone spicule pigmentary changes, moderate hyperAF, and a large cystic lesion in the foveal region in the right eye only. Patient II:5 shows a pattern
of atrophy predominantly of the nasal retina and AF findings similar to patient II:4, extended macular atrophy, and CME with epiretinal membranes
in both eyes. Composite fundus photography of patient II:1 (family B) reveals dotted hypopigmentation intermingled with bone spiculae, ring-
shaped hyperAF at the maculae, and a maintained macular laminar structure without CME or visible cystic lesions.
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at older ages (II:4 and II:5). In contrast, perimetry in patient
II:2 at age 67 years revealed a field loss with a residual central
and inferior-temporal island similar to that recorded in her son
at age 36 years (Fig. 5).
Ff-ERG results were consistent with rod-cone dysfunction,
with recognizable but severely reduced and slightly delayed
cone-mediated responses only in the index patient (III:1) aged
36 years. Here, the b-wave amplitude of the 3.0-cd/m2 light-
adapted (cone)18 response measured only 7.5 and 11.7 lV
(5th–95th percentile in our clinic: 101.5–263.5 lV) with a
significantly delayed response peak time of 34.5 and 41 ms in
the right and left eyes, respectively. Ff-ERG responses in his
mother (patient II:2) at age 67 years were not delayed and were
less severely affected, with recordable but severely reduced
3.0-cd/m2 dark- and light-adapted responses, the latter being
comparable in amplitude to those recorded contemporane-
ously in her son, despite an age difference of 31 years. Mf-ERG
recordings revealed a normal (both eyes in II:2) to reduced
(right eye in III:3) or delayed (left eye in III:1) central response,
corresponding to a better-preserved visual acuity in the eyes
with normal central mf-ERG responses (right eye in III:1; left
eye in III:3, both eyes in II:2) (Fig. 6).
Typical fundus changes suggestive of retinal dystrophy were
observed in all patients, although to a slightly lesser extent in
the two patients in their fourth decade compared to the two
older patients (aged 66 and 77 years) (Fig. 4). Bone spicule
pigmentation was more obvious in the midperiphery and
associated with mild maculopathy and optic disc pallor in
patients III:1 and III:3, whereas patient III:1 showed typical
tilted discs and peripapillary atrophy related to his high
myopia. Advanced chorioretinal atrophy (nasally more than
temporally), severe maculopathy, and atrophic optic discs were
visible in patients II:4 and II:5, corresponding to their longer
disease course at the time of examination. However, fundus
changes in patient II:2 were less severe despite the patient’s
age of 67 years. Retinal AF shows increased autofluorescence
within the central macula and reduced autofluorescence
corresponding to the atrophic fundus changes in all patients.
Analysis of the macular layers and their thicknesses revealed a
maintained laminar structure with atrophic outer retinal layers
and reduced central retinal thickness (CRT) and TMV (Table 2).
The macular ellipsoid zone was preserved in three patients of
different ages (III:1, III:3, II:2; 36, 37, and 67 years,
respectively). Cystoid macular edema was apparent to a
varying extent in all five patients within the extrafoveal inner
nuclear layer and, in patients III:1 (left eye) and III:3 (right
eye), also in in the parafoveal inner nuclear layer. None of the
OCT scans demonstrated changes suggestive of outer retinal
tubulations (Fig. 4).
Exome sequencing data analysis revealed a rare missense
mutation (c.3260C>T, p.(Ser1087Leu)) in SNRNP200, which
has been previously described19 (Fig. 2) and confirmed as
disease-associated through functional analysis.3 This variant has
a frequency of 1 in 246,000 alleles worldwide and 1 in 112,000
non-Finnish Europeans (gnomAD, August 2018). Segregation
analysis of this sequence variant by Sanger sequencing was
performed in the mother, unaffected sister, and affected aunt of
the index patient (Tables 3, 4). The identified sequence
variation in SNRNP200 was present in the mother and affected
aunt, but absent in the unaffected sister. Additional sequence
variations were detected in UNC119 and MYO7A (Table 3).
However, only the missense variation in SNRNP200 segregated
with RP in this family. The two compound heterozygous
missense variations in MYO7A were detected only in the index
patient (III:1) and may represent modifier alleles for the disease
in this patient, who had normal responses on audiometry and
no signs of vestibular dysfunction.
Family B: Autosomal Recessive RP Caused by a
Homozygous Missense Mutation (c.1634G>A,
p.(Arg545His)) in SNRNP200
The 10-year-old index patient of family B reported nyctalopia,
beginning around 1 year before initial examination, as his
only symptom. An avid football (soccer) player, he had not
noticed changes in his vision or his ability to participate in
games. On examination, his best-corrected visual acuity was
subnormal at 20/40 in both eyes. Perimetry showed
constricted kinetic isopters and a paracentral scotoma
verified with static test points (Fig. 5). Ff-ERG confirmed a
severe rod-cone dysfunction, with nonrecordable responses
under scotopic conditions, minimal responses under phot-
opic conditions, and a light-adapted 3.0-cd/m2 (cone) b-wave
response amplitude of 22.3 and 17.8 lm in the right and left
eyes, respectively. Localized response analysis of the mfERG
revealed normal cone-mediated responses within the central
58 in radius, but delayed and reduced responses outside this
retinal area (Fig. 6). Retinal examination showed marked
midperipheral to peripheral changes, with spotted or dot-like
hypopigmentation, bone-spicule pigmentation, and retinal
atrophy. OCT showed reduced retinal thickness, but no
cystoid macular changes were observed. The thinning of the
outer retinal layers, in particular of the ellipsoid zone,
corresponded with a perimacular ring of increased autofluo-
rescence (Fig. 4).
His asymptomatic parents (both aged 40) both demonstrat-
ed normal visual acuity, normal retinal morphology, and normal
ff-ERG findings (perimetric testing was omitted in the parents
due to these normal examination results).
Filtering of whole exome sequence data of 483 genes
related to ocular, and in particular retinal, diseases revealed
only one variant that also met the genetic criteria: c.1634G>A
(p.(Arg545His)) in the SNRNP200 gene (Tables 3, 4). This
variant was observed in the homozygous state in the index
patient and the heterozygous state in both parents and the
asymptomatic sister (Fig. 2). No frequency data were found in
public databases for this variant (Exome Sequencing Project
Variants, ClinVar, COSMIC, dbSNP, gnomAD, 1000 Genomes).
Prediction algorithms revealed the following values: Align
GVGD20 class C0 (GV 241.65, GD 1.62), SIFT deleterious21
(score: 0.02), MutationTaster22 disease causing (P value: 1),
PolyPhen-2 probably damaging23 (score: 0.999, sensitivity:
0.14, specificity 0.99), and MAPP bad24 (P value 0.007, P value-
median 0.003). In addition, EX-SKIP25 predicts a higher
probability of exon skipping for the variant compared to the
reference sequence. These results make the nucleotide
substitution c.1634G>A the most likely disease-causing variant
in the index patient of family B. Other most likely non–disease-
causing variants, which met filtering but not genetic criteria,
are listed in Table 3. CNV data analysis did not reveal any
suspicious alternations in the patient.
FIGURE 5. Kinetic visual fields are shown for all affected patients of family A and the one patient of family B. In family A, patients II:2, III:1, and III:3
show intact peripheral islands of varying extent, predominantly inferiorly and/or temporally. In contrast, patients II:4 and II:5 show residual central
islands only. Note that patient II:5 has no light perception in the right eye following an intracerebral meningioma. Patient II:1 from family B shows
an almost normal visual field with the largest stimulus tested (V4e), otherwise constricted (I4e).
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FIGURE 6. Multifocal ERG responses are shown for patients II:2, III:1, and III:3 of family A and patient II:1 of family B. All tested patients in family A
show reduced to nonrecordable responses outside the central stimulus area, with normal (II:1 both eyes; III:1 right eye; III:3 left eye) to slightly
abnormal (III:1 left eye delayed response; III:3 right eye reduced response) central responses. Patient II:1 of family B had normal responses in
approximately the central 58, with delayed and reduced responses outside this zone.
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DISCUSSION
Retinitis pigmentosa due to mutations in the SNRNP200 gene
was first suggested to cause autosomal dominant disease26,27
with a prevalence of 1.6% or more.28 Some reports point to
autosomal recessive inheritance, but no detailed phenotype
description or clinical assessment of the respective patients is
available (Table 5).9,11
The phenotype in the autosomal dominantly inherited
SNRRP200 mutation is characterized by an early but variable
disease onset as demonstrated in family A. Night blindness is
reported as the initial symptom starting between 5 and 15
years19,27,29; however, as known in autosomal dominant RP,
variability with late onset can occur, as seen in patient II:2.
Slow but inexorable progression has been described in patients
with different mutations in the SNRNP200 gene. Pan et al.19
suggested that patients harboring the mutation c.3260C>T
may be associated with a more severe phenotype than patients
with the mutation c.2042G>A. We therefore compared the
reported symptoms and age at onset, as well the phenotype, of
all mutations published to date4–12,19,27–36 in Table 5. Reduced
vision and night blindness, less often visual field changes, are
the most commonly reported symptoms. Age at onset varied
between early childhood to early adolescence. The age at onset
in our patient (II:2), in the sixth decade of life, is the oldest
recorded to date. The published retinal phenotype descrip-
tions are very limited, usually mentioning only ‘‘typical RP.’’
Maculopathy was described in a few cases,4,5,29,32 most of
them carrying the same mutation as in family A; however,
detailed or longitudinal imaging is not available in the
published cases. Retinal function is described as rod-cone
dysfunction except in one case with cone-rod dysfunction.8
More affected families and detailed longitudinal data would be
required in order to compare and correlate the phenotypic
effect of certain mutations in the SNRNP200 gene. Visual
acuity ranges from subnormal to no light perception.
Intrafamilial phenotype variability has been documented across
three generations of a Chinese family.37 As intrafamilial
variability is reported in autosomal dominant RP, disease-
modifying effects of identified SNPs in this report could be
possible.38–40
Here we described the detailed phenotype in autosomal
dominant RP in a Swiss family with the c.3260C>T missense
mutation in the SNRNP200 gene. Based on the reported
patients in the literature published to date, this mutation may
be a mutational ‘‘hot spot’’ as suggested by Benaglio et al.6
The index patient in our family A shows additional variants
in MYO7A and UNC119, which do not segregate with the
disease in the family and which do not result in auditory
dysfunction. This patient does not show a more severe
phenotype compared with the other affected family members
(excepting his mother, who exhibited a less severe pheno-
type). Visual acuity is subnormal to reduced in the fourth
decade to severely reduced in the seventh to eighth decade,
with associated advanced visual field defects. Similarly to the
intrafamilial variability reported by Liu et al.,37 the mother of
the index patient in family A exhibited a less severe functional
loss at age 67 compared to affected family members of her
generation. Disease progression was associated with cystoid
macular edema (as previously documented in 10%–50% of
patients with RP) within the inner nuclear layer only, due to a
greater extent of macular atrophy affecting the outer nuclear
TABLE 3. Summary of Mutation Information of the Index Patient in Family A and B
Gene Reference Sequence Exon/Intron RsID GnomAD Freq. DNA Level Protein Level Zyg.
Index patient family A
SNRNP200 NM_014014.4 Exon 25 rs267607077 0% c.3260C>T p.(Ser1087Leu) Het
UNC119 NM_005148.3 Exon 4a rs146916036 0.1% c.502C>T p.(Arg168Cys) Het
MYO7A NM_000260.3 Exon 35 rs370232066 0.02% c.4739A>G p.(Tyr1580Cys) Het
MYO7A NM_000260.3 Exon 39 rs762836180 0.03% c.5380G>A p.(Glu1794Lys) Het
Index patient family B
ABCA4 NM_000350.2 Exon 6 rs757844726 0.013% c.694C>T p.(Leu232Phe) Het
ADGRV1 NM_032119.3 Exon 28 rs41308846 0.80% c.6133G>A p.(Gly2045Arg) Het
SNRNP200 NM_014014.4 Exon 13 – – c.1634G>A p.(Arg545His) Hom
RsID, reference SNP cluster ID; Zyg, zygocity.
TABLE 4. Segregation Family A and B
Gene
Family A
Index A, III:1 II:1 III:2 II:4 II:5
Affected Affected Unaffected Affected Affected
SNRNP200, c.3260C>T, p.(Ser1087Leu) Het Het Reference Het Het
UNC119, c.502C>T, p.(Arg168Cys) Het Het Het Reference NS
MYO7A, c.4739A>G, p.(Tyr1580Cys) Het Het Het Reference NS
MYO7A, c.5380G>A, p.(Glu1794Lys) Het Reference Reference Reference NS
Family B
Index B Sister Mother Father
Affected Unaffected Unaffected Unaffected
SNRNP200, c.1634G>A, p.(Arg545His) Homo Het Het Het
Het, heterozygous; Homo, homozygous; NS, not sequenced.
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layer (as observed in the older patients in this family). Bowne
et al.28 described preserved cone mosaics within the cystoid
spaces (using adaptive optics scanning laser ophthalmoscopy)
in patients with a SNRNP200 mutation. Quantitative analysis of
these cone mosaics revealed an increased cone spacing that
nevertheless enabled a relatively good visual acuity of 20/63 in
the examined eye,28 a factor that may potentially explain the
well-preserved visual acuity in our patient II:2 at age 67 years.
RP caused by SNRNP200 mutations has not, to date, been
associated with extraocular manifestations. Liu et al.37 de-
scribed a family with associated angle closure glaucoma in two
of the five living patients with the c.3260C>T missense
mutation. No other reported associations are known to date.
Based on the patients described in our study together with
other reports (Pan et al.19), we cannot confirm additional
ocular or systemic manifestations. Therefore, angle closure
glaucoma in these patients may not be attributable to the
SNRNP200 gene mutation.
We observed phenotypical differences in the affected
patient with the homozygous mutation compared with the
heterozygous mutation. Excluding the mildly affected patient
II:2 in family A, disease onset and night blindness as the initial
early symptom does not differ between the two families with
the different inheritance pattern. However, the patient with
the homozygous recessive mutation experienced an earlier
reduction in visual acuity compared with the patients in family
A carrying the heterozygous dominant mutation. Fundus
changes are distinct, with speckled hypopigmentation, which
has not been previously reported for SNRNP200 mutations and
was not visible in the dominant family (Fig. 4). Retinal function
and morphology may also point to a more severe phenotype in
the patient with the recessive mutation, although longitudinal
data and additional affected patients are not available at the
present time. In the present study, ff-ERG responses in this
patient were already severely reduced by the age of 9 years.
OCT showed increased retinal thinning relative to the much
older patients with the dominant mutation in SNRNP200 (Fig.
4; Table 2), although the presence of cystoid macular edema in
the majority of the latter group of patients precludes a
quantitative comparison.
Phenotype variability may be associated with both the
dominant and recessive modes of inheritance of mutations in
the SNRNP200 gene. Wang et al.9 described the case of one
patient with LCA caused by a homozygous mutation
(c.3133C>A, p.(Pro1045Thr)) in the SNRNP200 gene (no
clinical details available).9 Astuti et al.11 described a likely
p a t hogen i c , homozygou s mu t a t i on c . 3269C>A
(p.(Arg1090Gln)) in a consanguineous family from Pakistan
with an affected child and his aunt, with the former showing
an early disease onset with a visual acuity reduction to 1.0
logMAR at the age of 15. The phenotype of the aunt was not
described. No other details or functional data are available from
these families of autosomal recessive inheritance.
The patient reported by Bujakowska et al.10 carried a
compound heterozygous deletion in the SNRNP200 and
CNNM4 genes. The authors did not discuss which of the gene
changes is causative. Two patients reported there were
carrying a heterozygous deletion of approximately 1.1 Mb
including 20 genes. Two of them, SNRNP200 and CNNM4, are
known retinal disease genes. Both of the two patients carry an
additional point mutation in either CNNM4 or SNRNP200,
compatible with an autosomal recessive mode of inheritance in
both cases.
Both autosomal dominant and recessive inheritance pat-
terns are already known for other genes associated with
nonsyndromic retinal dystrophies: Best1, IMPDH1, NR2E3,
NRL, SAG, RDH12, RP1, RPE65 (summarized in Verbakel et
al.41). Similarly to the above genes, autosomal dominant
SNRNP200 mutations appear to be associated with a less
severe RP disease course compared to the autosomal recessive
inheritance.
The p.(Arg545His) substitution in our patient in family B
lies in the more important and active N-terminal cassette of
the U5 small nuclear ribonucleoprotein 200-kDa helicase
(BRR2), which consists of two prototypical RecA-like ATPase
domains.42 The C-terminal cassette of BRR2 serves as an
intramolecular cofactor. The mutation lies in the first RecA
domain which forms the first contact with ATP, the energy
source of the helicase. Due to this position, the effect of
p.(Arg545His) may be similar to p.(Ser1087Leu), which
showed decreased RNA binding and reduced helicase
activity4 and is in close proximity to other autosomal
recessive inherited variants (Fig. 1). In addition, in close
proximity to amino acid position 545 of BRR2, other variants
causing a retinal phenotype have been published: p.(Ile538-
Met) (simplex RP),30 p.(Ala542Val) (autosomal dominant
RP),28 and p.(Met544Thr) (simplex RP).30 A similar situation
is found at amino acid position 1090 in the Sec63 domain of
the protein. There, a dominant as well as a recessive missense
exchange was described by Li et al.27 and Astuti et al.,11
respectively. We believe that a dominant variant leads to a
dominant negative effect in the protein, while a recessive
variant leads to loss of protein function. This is supported by
the findings of Bujakowska et al.,10 who described a
heterozygous deletion of SNRNP200 in an unaffected family
member. Thus, haploinsufficiency seems unlikely for domi-
nant variants in SNRNP200. Taken together, mutations in this
protein domain seem to cause the retinal phenotype and are
responsible for autosomal recessive RP, as in the index patient
of family B. Only two missense mutations out of 34
SNRNP200 variants from 47 publications, which are listed
in HGMD, have been functionally characterized p.S1087L and
p.R1090L.3 The respective functional studies for the two
variants were performed in HeLa cells using beta globin RNA
as the target of splicing. The results indicate some deleterious
effect of the two amino acid substitutions but only when the
endogenous SNRNP200 expression is knocked down. There-
fore, we believe that currently no proper functional assay is
available in order to study the effect of amino acid
substitutions in SNRNP200 with relevance to ocular or retinal
tissue or cells.
In summary, this report describes a novel recessive
mutation c.1634G>A (p.(Arg545His)) in the SNRNP200 gene
associated with a phenotype typical for juvenile RP. Functional
analysis of this sequence variant will be required to provide
evidence for the association with disease. Such functional
studies are also necessary prior to the application of gene
therapeutic approaches in patients. Visual dysfunction may be
more severe than in patients with the dominantly inherited
SNRNP200 mutation. However, detailed genotype–phenotype
correlation and verification of the mechanisms leading to
autosomal recessive or dominant disease will be possible only
through future functional studies. Awareness of the possibility
of dominant and recessive inheritance pattern and severe
phenotypes such as LCA should be taken into account when
counseling patients and family members.
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